Variables | Training cohort | Validation cohort | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | Multivariate analysis | ||||||||
HR | 95%CI | p | HR | 95%CI | p | HR | 95%CI | p | ||
Gender | Male | 0.931 | 0.451–1.923 | 0.847 | \ | \ | \ |  |  |  |
Female | ||||||||||
Tumor size(cm) | ≤3 | 2.822 | 1.406–5.650 | 0.004 | 1.910 | 0.897–4.070 | 0.035 | \ | \ | 0.139 |
> 3 | ||||||||||
Vascular invasion | Present | 3.52 | 1.701–7.287 | 0.001 | 1.794 | 0.797–4.037 | 0.008 | \ | \ | 0.982 |
Absent | ||||||||||
Micro-vascular invasion | Present | 1.084 | 0.574–2.051 | 0.803 | \ | \ | \ | \ | \ | \ |
Absent | ||||||||||
Differentiation | III-IV | 1.515 | 0.886–2.592 | 0.129 | \ | \ | \ | \ | \ | \ |
I-II | ||||||||||
Liver Cirrhosis | Yes | 1.113 | 0.838–1.479 | 0.458 | \ | \ | \ | \ | \ | \ |
No | ||||||||||
HBsAg | Present | 1.557 | 0.662–3.664 | 0.31 | \ | \ | \ | \ | \ | \ |
Absent | ||||||||||
Tumor encapsulation | Absent | 2.105 | 1.155–3.846 | 0.015 | 2.326 | 1.272–4.255 | 0.006 | \ | \ | 0.394 |
Present | ||||||||||
Rad-score | ≤4.32 | 2.387 | 1.321–4.310 | 0.004 | 2.283 | 1.261–4.132 | 0.006 | 3.236 | 1.416–7.407 | 0.005 |
> 4.32 | ||||||||||
DBIL, μmol/L | 1.015 | 0.998–1.031 | 0.084 | \ | \ | \ | \ | \ |  | |
TBIL, μmol/L | 1.012 | 0.998–1.026 | 0.102 | \ | \ | \ | \ | \ | \ | |
ALT, U/L | 0.998 | 0.991–1.005 | 0.57 | \ | \ | \ | \ | \ | \ | |
AST, U/L | 1.000 | 0.995–1.005 | 0.946 | \ | \ | \ | \ | \ | \ | |
AFP, ng/ml | 1.000 | 1.000–1.000 | 0.189 | \ | \ | \ | \ | \ | \ | |
ALB, g/L | 1.020 | 0.964–1.079 | 0.495 | \ | \ | \ | \ | \ | \ | |
GGT, U/L | 1.004 | 1.003–1.006 | < 0.0001 | 1.004 | 1.002–1.006 | < 0.0001 | \ | \ | 0.249 |